SCHEMBL6184844

SCHEMBL6184844

Cc1cccc(C)c1C(=O)c1c(C)[nH]c2ccc([N+](=O)[O-])cc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
POLB P06746 2/20 0.53
PKM P14618 1/20 0.53
NPY1R P25929 1/20 0.53
NPY2R P49146 1/20 0.53
MAPT P10636 6/20 0.50
LMNA P02545 1/20 0.50
KDM4E B2RXH2 1/20 0.48
GAA P10253 1/20 0.48
HTR2A P28223 1/20 0.47
HTR6 P50406 1/20 0.47
CTSV O60911 1/20 0.46
CTSL P07711 1/20 0.46
PARP1 P09874 1/20 0.46
CA12 O43570 2/20 0.45
CA9 Q16790 2/20 0.45
CYP19A1 P11511 1/20 0.44
GFER P55789 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6186570 0.88 ALDH1A1 (0.51) ALDH1A1MEN1KMT2APOLBPKM
SCHEMBL28524078 0.86 MEN1 (0.58) ALDH1A1MEN1KMT2APOLBPKM
SCHEMBL6186801 0.85 ALDH1A1 (0.51) ALDH1A1MEN1KMT2APOLBPKM
SCHEMBL6189554 0.83 ALDH1A1 (0.46) ALDH1A1MEN1KMT2APOLBPKM
SCHEMBL28362604 0.82 POLB (0.59) ALDH1A1MEN1KMT2APOLBPKM
SCHEMBL5327852 0.82 ALDH1A1 (0.68) ALDH1A1MEN1KMT2APOLBPKM
SCHEMBL11250386 0.81 ALDH1A1 (0.56) ALDH1A1MEN1KMT2APOLBPKM
SCHEMBL6187137 0.81 ALDH1A1 (0.45) ALDH1A1MEN1KMT2APOLBPKM
SCHEMBL6634172 0.79 MAPT (0.56) ALDH1A1MEN1KMT2APOLBPKM
SCHEMBL27136306 0.78 ALDH1A1 (0.54) ALDH1A1MEN1KMT2APOLBPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554271-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2005-07-20 EP disclosed
WO-2004035571-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2004-04-29 WO disclosed